En Carta Diagnostics vs NanoStruct
En Carta Diagnostics vs NanoStruct, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: En Carta Diagnostics is on 52/100 and NanoStruct on 53/100.
Where each one leads
En Carta Diagnostics
- funding raised: $5.0M against $2.9M
NanoStruct
- domain rating: 24/100 against 0/100
- headcount: 15 against 12
At a glance
| Measure | En Carta Diagnostics | NanoStruct |
|---|---|---|
| What it is | Developing a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity. | Develops nanostructured sensor chips for rapid pathogen identification in food. |
| Category | Biotechnology, HealthTech, Diagnostics, Medical Devices | Biotechnology, Food Technology, Nanotechnology, Diagnostics |
| Sells toBusiness model | B2B2C | B2B |
| Offering | Hardware | Hardware |
| Founded | 2022 | 2021 |
| Headquarters | Paris, France | Würzburg, Germany |
| Status | Inactive | Active |
Size, funding and growth
| Measure | En Carta Diagnostics | NanoStruct |
|---|---|---|
| Employees | 12 | 15 |
| Total funding | $5.0M | $2.9M |
| Latest round | Seed | Seed |
| LinkedIn followers | 2,091 | 1,974 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | En Carta Diagnostics | NanoStruct |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 52/100 | 53/100 |
| Traction | 45/100 | 44/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 20/100 | 39/100 |
| Quality | 58/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | Not published | F (22/100) |
| Domain ratingLink authority, 0-100 | 0/100 | 24/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | En Carta Diagnostics | NanoStruct |
|---|---|---|
| Hosting | Not detected | Self Managed |
| Frameworks | Not detected | Bootstrap |
En Carta Diagnostics vs NanoStruct: common questions
Which is better, En Carta Diagnostics or NanoStruct?
On our 0-100 score NanoStruct rates higher (53/100 against 52/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do En Carta Diagnostics and NanoStruct compare on the numbers?
En Carta Diagnostics leads on funding raised ($5.0M against $2.9M). NanoStruct leads on domain rating (24/100 against 0/100), headcount (15 against 12).
Read the full En Carta Diagnostics review and pricing or the NanoStruct review and pricing. You can also browse other En Carta Diagnostics alternatives we track.